Cargando…
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559141/ https://www.ncbi.nlm.nih.gov/pubmed/37413676 http://dx.doi.org/10.1513/AnnalsATS.202303-229RL |
_version_ | 1785117432665341952 |
---|---|
author | Nathan, Steven D. Medarov, Boris Ho, Lawrence Kingrey, John Hong, Taekwon Rao, Youlan Shen, Eric Smith, Peter Deng, Chunqin Waxman, Aaron |
author_facet | Nathan, Steven D. Medarov, Boris Ho, Lawrence Kingrey, John Hong, Taekwon Rao, Youlan Shen, Eric Smith, Peter Deng, Chunqin Waxman, Aaron |
author_sort | Nathan, Steven D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10559141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105591412023-10-08 A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial Nathan, Steven D. Medarov, Boris Ho, Lawrence Kingrey, John Hong, Taekwon Rao, Youlan Shen, Eric Smith, Peter Deng, Chunqin Waxman, Aaron Ann Am Thorac Soc Letters American Thoracic Society 2023-10-01 /pmc/articles/PMC10559141/ /pubmed/37413676 http://dx.doi.org/10.1513/AnnalsATS.202303-229RL Text en Copyright © 2023 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern. |
spellingShingle | Letters Nathan, Steven D. Medarov, Boris Ho, Lawrence Kingrey, John Hong, Taekwon Rao, Youlan Shen, Eric Smith, Peter Deng, Chunqin Waxman, Aaron A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title | A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title_full | A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title_fullStr | A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title_full_unstemmed | A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title_short | A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial |
title_sort | novel approach to clinical change endpoints: a win ratio analysis of the increase trial |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559141/ https://www.ncbi.nlm.nih.gov/pubmed/37413676 http://dx.doi.org/10.1513/AnnalsATS.202303-229RL |
work_keys_str_mv | AT nathanstevend anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT medarovboris anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT holawrence anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT kingreyjohn anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT hongtaekwon anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT raoyoulan anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT sheneric anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT smithpeter anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT dengchunqin anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT waxmanaaron anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT nathanstevend novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT medarovboris novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT holawrence novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT kingreyjohn novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT hongtaekwon novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT raoyoulan novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT sheneric novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT smithpeter novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT dengchunqin novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial AT waxmanaaron novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial |